Skip to main content

Healthcare security reports

Browse 6,582 Guard analyses across this slice of the directory — NIS2 / GDPR readiness, SSL/TLS, DNS hygiene and email authentication.

Live Guard activity

Security teams are checking their sites with Guard right now

Run your domain before the queue fills up

156979
Websites
130
Industries
113
Countries
52
Avg Score
Page 73 of 132|Showing 3601-3650 of 6582
zentiva.hu favicon

Zentiva Pharma Kft.

zentiva.hu

78
HealthcareHungarylargeLOW

Zentiva Pharma Kft. is a significant player in the Hungarian generic pharmaceutical market, providing high-quality, affordable medicines to patients. The company operates as part of the larger Zentiva Group, with a broad presence across Europe and India. The website reflects a professional business model focused on pharmaceutical manufacturing and distribution, targeting patients and healthcare providers in Hungary. The site content is well-structured, with clear branding and consistent messaging about their role in the healthcare sector. Technically, the website employs modern web technologies including JavaScript libraries, Google Tag Manager for analytics, and Cookiebot for GDPR-compliant cookie consent management. The site is mobile-optimized and uses HTTPS with strong SSL configuration, ensuring secure communications. Accessibility features are basic but present, and SEO practices are adequately implemented. From a security perspective, the site demonstrates good practices such as HTTPS enforcement, CSRF protection cookies, and a comprehensive cookie consent mechanism. However, it lacks explicit security policies or incident response contact information, and security headers are not visibly configured. No critical vulnerabilities or suspicious content were detected. Overall, the website is trustworthy, compliant with GDPR, and professionally maintained. Strategic improvements could include publishing a security policy, adding Terms of Service, and enhancing security headers to further strengthen the security posture.

70
100
17
85
82
85
100
pharmaceuticalhealthcaregenericmedicinescookieconsentgdprcompliant
JavaScriptGoogle Tag ManagerCookiebotModernizr+2

Partner Domains:

zentiva.com
parent
cookiebot.com
partner
2025-09-07T11:47:25.077Z
V

Vipharm Slovakia s.r.o.

vipharm.sk

44
HealthcareSlovakiamediumHIGH

Vipharm Slovakia s.r.o. is a Slovak branch of a Polish pharmaceutical company specializing in the research, production, and sale of high-quality specialized medicines primarily in neurology, psychiatry, and oncology. The company emphasizes compliance with EU standards and quality assurance throughout its manufacturing processes. Their website serves both healthcare professionals and patients, offering educational content and support services including adverse effect reporting. The company maintains a medium-sized market presence with a focus on specialized pharmaceutical products and patient education initiatives. Technically, the website is built on WordPress 4.1.41 with common plugins such as LayerSlider and Contact Form 7. The technology stack includes older versions of jQuery and lacks modern security headers, indicating moderate digital maturity. The site is moderately optimized for performance and mobile use but could benefit from updates and enhanced accessibility features. From a security perspective, the site uses HTTPS but runs outdated software versions that may expose it to vulnerabilities. No advanced security headers are present, and there is no cookie consent mechanism, which may impact GDPR compliance. Contact information is clearly provided, enhancing business credibility. No signs of malware or phishing were detected. Overall, the website is functional and professional but requires technical and security improvements to enhance its posture and compliance. Strategic updates to software, implementation of security headers, and privacy enhancements are recommended to reduce risk and improve trust.

15
10
2
10
67
75
100
pharmaceuticalhealthcareneurologypsychiatryoncology+2 more
jQuery 1.11.1LayerSlider pluginContact Form 7 pluginSuperfish menu+2

Partner Domains:

pilulka.sk
partner
medseminar.sk
partner
2025-09-07T10:42:13.157Z
T

Teva Slovakia

teva.sk

70
HealthcareSlovakiaenterpriseMEDIUM

Teva Slovakia operates as a pharmaceutical manufacturing and distribution company, specializing in generic, specialty, and over-the-counter medicines. It holds a significant manufacturing facility in Opava producing billions of pharmaceutical units annually, serving over 50 markets including Slovakia. The company emphasizes patient-centric health initiatives and community engagement, positioning itself as a major player in the healthcare sector. The website reflects a professional corporate presence with clear navigation and multilingual support, targeting healthcare professionals and patients alike. Technically, the site employs modern JavaScript libraries, cookie consent management via OneTrust, and monitoring tools such as Microsoft Azure Application Insights and Microsoft Clarity, indicating a mature digital infrastructure. Security posture is solid with HTTPS enforced and monitoring tools in place, though explicit security headers and policies are not prominently published. Privacy compliance is supported by a cookie consent mechanism but lacks visible privacy and terms of service documentation in the provided content. Overall, the domain registration and WHOIS data align well with the corporate identity, supporting legitimacy and trustworthiness.

55
88
2
88
75
70
100
pharmaceuticalhealthcarecorporatecookie-consentanalytics+1 more
jQuery 3.5.1jQuery UI 1.13.2Popper.jsOneTrust Cookie Consent+2

Partner Domains:

www.tevapharm.com
parent
2025-09-07T10:41:27.365Z
canjhealthtechnol.ca favicon

CADTH

canjhealthtechnol.ca

45
HealthcareCanadamediumHIGH

The Canadian Journal of Health Technologies is an open-access scientific and policy journal published by CADTH, the Canadian Agency for Drugs and Technologies in Health. It serves healthcare professionals, policymakers, and researchers by providing timely reimbursement recommendations, reviews, and health technology assessments. The journal operates on a monthly publication cycle and leverages a specialized academic publishing platform to deliver content. The website reflects a professional and consistent brand aligned with its parent organization, CADTH, and targets a Canadian healthcare audience. Technically, the website is built on Open Journal Systems CMS version 3.3.0.8, incorporating modern web technologies such as Google Analytics, Google Tag Manager, Twitter tracking, MathJax for mathematical rendering, and Ionicons for iconography. The site is mobile-optimized with good navigation and SEO practices, though accessibility features are basic. Hosting and domain registration are managed through Rebel.ca, with domain registration details consistent with the organization's identity. From a security perspective, the site uses HTTPS with a good SSL configuration and domain status protections to prevent unauthorized transfers or updates. However, DNSSEC is not enabled, and no security headers were detected, which are areas for improvement. The absence of privacy and cookie policies, as well as incident response or vulnerability disclosure information, indicates gaps in compliance and transparency. Tracking scripts are present, suggesting moderate user tracking without explicit consent mechanisms. Overall, the website is trustworthy, professional, and serves its intended audience well but would benefit from enhanced privacy compliance, security hardening, and transparency measures to improve user trust and regulatory adherence.

20
35
2
70
62
55
40
healthcarejournalacademicopen-accesscadth+1 more
Open Journal Systems 3.3.0.8Google AnalyticsGoogle Tag ManagerTwitter Universal Website Tag+3

Partner Domains:

www.cadth.ca
parent
2025-09-07T10:18:19.170Z
bpsalliance.org favicon

Bio-Process Systems Alliance

bpsalliance.org

57
HealthcareUnited StatesmediumMEDIUM

The Bio-Process Systems Alliance (BPSA) is a well-established international industry association focused on advancing single-use technologies in biopharmaceutical manufacturing. Founded in 2005, it serves a global audience of industry professionals, sponsors, and members by providing resources, technical guides, events, and advocacy to promote safe and sustainable manufacturing practices. The website reflects a mature organization with a clear mission and professional presentation. Technically, the website is built on WordPress with modern plugins and libraries such as Swiper.js and Google Tag Manager. Hosting appears to be on AWS infrastructure, and the site is secured with HTTPS and domain transfer lock. Performance and mobile optimization are good, with accessibility and SEO features well implemented. However, DNSSEC is not enabled, and no cookie consent mechanism is present, which could affect compliance in certain jurisdictions. From a security perspective, the site follows basic best practices including HTTPS and protection against user enumeration. There is no visible security policy or incident response contact information, which is a gap for transparency and readiness. No vulnerabilities or sensitive data exposures were detected. Overall, the security posture is solid but could be improved with enhanced policies and DNSSEC. The overall risk assessment is low, with the website demonstrating high professionalism, trustworthiness, and business credibility. Strategic recommendations include enabling DNSSEC, implementing cookie consent for GDPR compliance, publishing security and incident response policies, and ongoing monitoring of third-party scripts. These steps will enhance security, compliance, and user trust.

15
53
2
70
62
70
100
biopharmaceuticalsingle-usetechnologiesindustryassociationhealthcaremanufacturing+4 more
WordPress 6.8.2WP RocketSwiper.jsGoogle Tag Manager+1
2025-09-07T09:15:52.252Z
mabion.eu favicon

Mabion

mabion.eu

60
HealthcarePolandmediumMEDIUM

Mabion is a European Contract Development and Manufacturing Organization (CDMO) specializing in biologics pharmaceutical services. The company offers a comprehensive suite of end-to-end services including drug substance manufacturing, fill & finish, gene to vial development, process development, analytics, and cell line development & banking. Positioned as a trusted partner for pharma and biotech companies, Mabion emphasizes high-quality standards, innovation, and client-centric solutions. The company is headquartered in Poland, strategically located in the heart of Europe, and benefits from European Union funding and recognized certifications such as GMP, GCP, and ISO. Technically, the Mabion website is built on WordPress using the Veneo theme, incorporating modern JavaScript libraries like Swiper and LazyLoad for enhanced user experience and performance. The site is mobile-optimized, fast-loading, and SEO-friendly, with comprehensive metadata and structured data for improved search visibility. Security measures include HTTPS enforcement, strong security headers, and secure contact forms with reCAPTCHA integration. From a security perspective, Mabion demonstrates a mature posture with no visible vulnerabilities or exposed sensitive data. Privacy compliance is robust, featuring a detailed privacy policy, cookie consent mechanisms, and GDPR adherence. However, explicit security policies and incident response information are not publicly available, representing an area for improvement. Overall, Mabion presents a professional, trustworthy, and well-maintained digital presence aligned with its business objectives. The lack of WHOIS transparency is mitigated by strong on-site trust signals and consistent business information. Strategic recommendations include publishing security policies, vulnerability disclosure channels, and data protection officer contacts to further enhance trust and compliance.

15
28
17
100
47
85
100
cdmopharmabiologicshealthcarecontractmanufacturing+2 more
WordPressGoogle Tag ManagerGoogle AnalyticsContact Form 7+2
2025-09-07T09:12:09.446Z
ipa-india.org favicon

Indian Pharmaceutical Alliance

ipa-india.org

56
HealthcareIndialargeMEDIUM

The Indian Pharmaceutical Alliance (IPA) is a prominent industry alliance representing 23 leading Indian pharmaceutical companies. Established in 1999, IPA focuses on policy advocacy, innovation promotion, quality standards, and expanding the global reach of Indian pharmaceuticals. The website reflects a mature digital presence built on Drupal 11, featuring rich content including reports, articles, and multimedia resources. The organization maintains a strong social media footprint and positions itself as a key influencer in pharmaceutical policy and industry standards in India and globally. Technically, the website employs modern web technologies including jQuery, Bootstrap, and slick carousel for enhanced user experience. It is mobile-optimized and accessible with good SEO practices. Security posture is solid with HTTPS enforced and secure form validation, though it lacks some advanced security headers and explicit incident response information. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism or detailed GDPR compliance statements. Overall, the IPA website demonstrates a high level of professionalism and trustworthiness, consistent with its role as a leading pharmaceutical industry alliance. The lack of WHOIS registrant details is mitigated by the domain's age and alignment with the organization's identity. Strategic recommendations include enhancing privacy compliance, adding security headers, and publishing incident response and vulnerability disclosure policies to further strengthen trust and security.

40
53
25
75
82
70
20
pharmaceuticalhealthcarepolicyinnovationindia+1 more
Drupal 11jQuery 3.7.1Slick CarouselFancybox+3

Partner Domains:

pageindia.org
partner
2025-09-07T09:11:37.833Z
canadianbiosimilarsforum.ca favicon

Canadian Biosimilars Forum

canadianbiosimilarsforum.ca

59
HealthcareCanadasmallMEDIUM

The Canadian Biosimilars Forum is a Canadian alliance representing companies across the biosimilars industry, focused on increasing awareness, access, and adoption of biosimilars nationwide. Their website serves as an informational and advocacy platform, targeting healthcare professionals, policymakers, and patients interested in biosimilars. The organization positions itself as a key industry advocate with a focus on education and policy influence. Technically, the website is built on the Squarespace platform, leveraging modern web technologies including Google Tag Manager and Google Analytics for tracking. The site is mobile-optimized with good design quality and clear navigation, though accessibility features are basic. Performance is moderate, typical of CMS-hosted sites. From a security perspective, the site enforces HTTPS and avoids exposing sensitive data. However, it lacks several security headers and does not publish a privacy policy or cookie consent mechanism, which are important for compliance with privacy regulations such as GDPR. No incident response or security policy information is available, indicating room for improvement in transparency and security posture. Overall, the site is professional and trustworthy with a strong business credibility score. The absence of WHOIS data limits domain registration transparency but is consistent with privacy protection norms. Strategic recommendations include implementing privacy and cookie policies, adding security headers, and publishing security and incident response information to enhance trust and compliance.

35
35
17
70
62
75
100
biosimilarshealthcarecanadapharmaceuticalsadvocacy+1 more
SquarespaceGoogle Tag ManagerGoogle AnalyticsTypekit Fonts
2025-09-07T09:11:02.302Z
B

British Generic Manufacturers Association Ltd trading as Medicines UK

britishbiosimilars.co.uk

39
HealthcareUnited KingdommediumHIGH

Medicines UK, operating as the British Generic Manufacturers Association Ltd, is a UK-based trade association focused on the generic and biosimilar medicines sector. Their British Biosimilars Association (BBA) sector group promotes access to high quality biosimilar medicines, collaborating with healthcare professionals, regulators, and the NHS to support sustainable use and education. The website content is professional and targeted at healthcare stakeholders and patients interested in biosimilars. The technical infrastructure relies on legacy JavaScript libraries such as jQuery 1.11.3 and jQuery UI 1.11.4, with additional UI components like Swiper and Magnific Popup. The site is moderately optimized for mobile and performance but lacks modern CMS or advanced frameworks. No forms or analytics scripts were detected, indicating a low data collection footprint. Security posture is moderate with HTTPS implied but no explicit security headers detected in the provided data. The absence of WHOIS domain registration data is a concern for transparency and trust, although the website content and business information appear legitimate. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism visible. Overall, the website presents a professional front for a healthcare trade association but would benefit from improved domain transparency, enhanced security headers, and stronger privacy compliance measures.

15
53
2
70
-
75
20
biosimilarshealthcaretradeassociationmedicinesuk+1 more
jQuery 1.11.3jQuery UI 1.11.4SwiperMagnific Popup+1
2025-09-07T09:10:57.238Z
gabionline.net favicon

Generics and Biosimilars Initiative

gabionline.net

56
HealthcareN/amediumMEDIUM

The Generics and Biosimilars Initiative (GaBI) operates a well-established online platform providing comprehensive news, research, and policy information focused on generic and biosimilar medicines. Founded in 2008, the website serves healthcare professionals, pharmaceutical industry stakeholders, and policy makers with up-to-date editorial content and specialized resources. The platform maintains a strong market position as a niche media provider in the healthcare sector, emphasizing cost-effective treatment options. Technically, the website leverages a mature technology stack including IBEXA CMS, Bootstrap, YUI, and jQuery, supported by Google Fonts and Font Awesome for design consistency. Hosting is provided by Hosting Concepts B.V., with domain registration dating back to 2008, indicating a stable digital presence. The site is mobile-optimized and demonstrates good SEO practices, although some modernization opportunities exist, such as updating jQuery and enabling DNSSEC. From a security perspective, the site uses HTTPS and has domain transfer protections in place. However, it lacks DNSSEC and explicit security headers, and no published security or incident response policies were found. Cookie consent is implemented, and privacy policies are comprehensive and GDPR compliant. No critical vulnerabilities or suspicious content were detected, and the site maintains a high trustworthiness rating. Overall, GaBI presents a professional, secure, and privacy-conscious web presence suitable for its target audience. Strategic improvements in security headers, DNSSEC, and incident response transparency could further enhance its security posture and trustworthiness.

15
53
17
60
42
75
100
healthcarepharmaceuticalsgenericsbiosimilarsnews+2 more
YUI 3.17.2jQuery 1.10.2BootstrapFont Awesome+3
2025-09-07T09:10:52.223Z
centerforbiosimilars.com favicon

Center for Biosimilars

centerforbiosimilars.com

58
HealthcareUnited StatesmediumMEDIUM

The Center for Biosimilars is a specialized healthcare information platform focused on providing professionals with insights on biosimilars, health economics, regulatory outcomes, and emerging treatment paradigms. Founded in 2016 and operated under MJH Life Sciences, the website serves a niche audience of healthcare professionals and biosimilar industry stakeholders. The platform offers news, analysis, and educational content relevant to the biosimilars market. Technically, the website leverages modern web technologies including React and Next.js frameworks, with integrations for analytics and consent management such as Google Analytics, Segment, Algolia Insights, and OneTrust. The site demonstrates good mobile optimization and SEO practices, although some accessibility features could be enhanced. Performance is moderate, with a well-structured and professional design. From a security perspective, the site enforces HTTPS and uses consent management for cookies and tracking. However, it lacks explicit security headers and publicly available security policies or incident response contacts. The absence of WHOIS data for the domain raises some concerns about domain registration legitimacy, although the professional content and known parent company mitigate this risk. Overall, the website presents a credible and professional front for its business niche but would benefit from improved transparency in domain registration, explicit privacy and security policies, and enhanced security header implementation to strengthen trust and compliance.

30
88
17
70
-
85
100
biosimilarshealthcarebiosimilardrugshealtheconomicsregulatoryoutcomes+1 more
Next.jsReactGoogle Tag ManagerGoogle Analytics+4
2025-09-07T09:10:42.082Z
grxbiosims.org favicon

Association for Accessible Medicines

grxbiosims.org

55
HealthcareUnited StatesmediumMEDIUM

The website grxbiosims.org represents the Generic + Biosimilar Medicines Conference, a leading event organized by the Association for Accessible Medicines focused on the U.S. generics and biosimilars industry. It serves as a premier platform for regulatory, scientific, and policy professionals to gain insights, network, and stay informed about industry developments. The site features comprehensive event information, speaker highlights, sponsorship opportunities, and registration links, positioning itself as a key industry resource. Technically, the website is built on WordPress with a modern tech stack including WPBakery Page Builder, Yoast SEO, and multiple analytics and marketing tools such as Google Analytics, Facebook Pixel, and LinkedIn Insight Tag. The site is hosted likely via GoDaddy and uses HTTPS with good SSL configuration. Mobile optimization and SEO practices are well implemented, though accessibility features are basic. From a security perspective, the site employs HTTPS and some security best practices but lacks explicit security headers and public security or incident response policies. DNSSEC is not enabled, and no cookie consent mechanism is present despite GDPR compliance plugins, indicating room for improvement in privacy compliance. The domain registration uses privacy protection, which is justified for this type of non-profit event site. Overall, the website is professional, trustworthy, and well-positioned in its niche, with a strong business credibility score. Strategic recommendations include enabling DNSSEC, implementing a cookie consent banner, publishing security and incident response policies, and auditing third-party scripts for vulnerabilities to enhance security and compliance posture.

15
65
17
40
47
75
100
healthcareconferencegenericsbiosimilarsregulatory+2 more
WordPressWPBakery Page BuilderYoast SEOGoogle Analytics+6

Partner Domains:

accessiblemeds.org
partner
biosimilarscouncil.org
partner

+1 more partners

2025-09-07T08:08:26.717Z
igbamedicines.org favicon

International Generic and Biosimilar medicines Association - IGBA

igbamedicines.org

42
HealthcareSpainmediumHIGH

The International Generic and Biosimilar Medicines Association (IGBA) is a globally recognized industry association representing manufacturers and associations involved in generic and biosimilar medicines. Founded in 2015 and headquartered in Spain with operational presence in Geneva, Switzerland, IGBA focuses on advocacy, policy development, and promoting access to affordable, quality medicines worldwide. The website serves as a professional platform providing industry news, reports, events, and educational resources targeted at stakeholders in the pharmaceutical sector. Technically, the website is built on the Joomla CMS platform, utilizing JavaScript frameworks such as MooTools and jQuery, alongside third-party tools like Widgetkit and RokSprocket for enhanced UI components. The site is hosted by Hosting Concepts B.V. and employs HTTPS with a valid SSL certificate, ensuring secure communications. While the site demonstrates good mobile optimization and SEO practices, some technical debt is evident through the use of outdated JavaScript libraries, which could pose security risks. From a security perspective, the site enforces HTTPS and includes a cookie consent mechanism aligned with GDPR requirements. However, it lacks advanced security headers and does not publicly disclose a security policy or incident response contacts. DNSSEC is not enabled, and the presence of older JavaScript libraries suggests potential vulnerabilities. The WHOIS data is consistent and transparent, reinforcing the legitimacy of the domain and organization. Overall, IGBA's website is a credible and professional resource for the generic and biosimilar medicines industry, with a solid foundation in privacy compliance and business credibility. Security posture is moderate, with room for improvement in modernizing technical components and enhancing security policies. Strategic recommendations include updating libraries, enabling DNSSEC, implementing security headers, and publishing security and incident response information to strengthen trust and resilience.

15
53
2
70
62
55
-
healthcaregenericmedicinesbiosimilarsindustryassociationpharmaceuticals+2 more
Joomla CMSMooTools JavaScript frameworkjQuery 1.8.2Widgetkit+3
2025-09-07T06:58:43.124Z
biosimilarscanada.ca favicon

Biosimilars Canada

biosimilarscanada.ca

50
HealthcareCanadasmallMEDIUM

Biosimilars Canada is a national industry association dedicated to representing and advocating for the biosimilar medicines sector in Canada. The organization focuses on educating stakeholders including patients, healthcare providers, employers, and policymakers about the safety, efficacy, and benefits of biosimilars. Their market position is that of a trusted national voice promoting biosimilar adoption and policy support. The website reflects a professional and consistent brand image with clear navigation and relevant content tailored to their target audience. Technically, the website is built on WordPress using Elementor and JupiterX theme, leveraging modern SEO and performance optimization plugins such as Yoast SEO and WP Rocket. The site is mobile optimized and uses Google Analytics and Tag Manager for tracking. Hosting and domain registration are stable and appropriate for the organization's profile. From a security perspective, the site uses HTTPS with a good SSL configuration and domain status protections. However, DNSSEC is not enabled, and no explicit security or incident response policies are published on the site. Cookie consent mechanisms are absent despite the use of tracking scripts, indicating a gap in privacy compliance. No critical vulnerabilities or suspicious indicators were found. Overall, the website presents a low-risk profile with good business credibility and technical implementation. Strategic improvements in privacy compliance and security headers would enhance the security posture and trustworthiness further.

15
53
17
85
62
85
-
healthcarebiosimilarsindustryassociationcanadaeducation+1 more
WordPressElementorJupiterX themeYoast SEO+3

Partner Domains:

canadiangenerics.ca
partner
igbamedicines.org
partner
2025-09-07T06:58:38.114Z
dcatvci.org favicon

Drug, Chemical & Associated Technologies Association

dcatvci.org

59
HealthcareUnited StatesmediumMEDIUM

DCAT Value Chain Insights is a specialized online information resource produced by the Drug, Chemical & Associated Technologies Association, focusing on news and analysis relevant to the pharmaceutical development and manufacturing industry. The website serves industry professionals by providing timely updates, podcasts, sponsored content, and advertising opportunities, positioning itself as a niche media platform within the healthcare sector. The parent organization is a not-for-profit business development association, lending credibility and industry alignment to the website's content and mission. Technically, the website is built on WordPress with a modern plugin ecosystem including Yoast SEO, Adsanity for ad management, and SearchWP for enhanced search capabilities. It is hosted likely on WP Engine, ensuring reliable performance and scalability. The site demonstrates good mobile optimization and SEO practices, though accessibility features are basic. Analytics are implemented via Google Analytics and Google Tag Manager, indicating moderate user tracking. From a security perspective, the site enforces HTTPS and uses some security plugins but lacks explicit security headers and a cookie consent mechanism, which are areas for improvement. No vulnerabilities or exposed sensitive data were detected in the content. The WHOIS data is unavailable due to privacy protection, which is common and justified for this type of organization. Overall, the security posture is solid but could be enhanced with additional headers and compliance features. The overall risk assessment is low, with the website presenting a professional, trustworthy, and well-maintained digital presence. Strategic recommendations include implementing cookie consent for GDPR compliance, adding security headers, publishing a security policy and incident response contacts, and maintaining regular updates to the WordPress core and plugins to mitigate vulnerabilities.

15
53
17
85
42
75
100
pharmaceuticalindustrynewshealthcarebiopharmacdmo+2 more
WordPressYoast SEOGoogle Analytics (gtag.js)jQuery+3
2025-09-07T06:58:33.105Z
biosimilarscouncil.org favicon

Biosimilars Council

biosimilarscouncil.org

55
HealthcareUnited StatesmediumMEDIUM

The Biosimilars Council is a U.S.-based healthcare advocacy organization focused on promoting biosimilar medicines. It operates as a division of the Association for Accessible Medicines and serves as a leading resource for biosimilar education, policy advocacy, and industry research. The website reflects a mature digital presence with rich content including press releases, reports, and event information targeting healthcare professionals, policymakers, and industry stakeholders. The organization positions itself as a key player in shaping biosimilar policy and market development in the U.S. Technically, the website is built on WordPress with modern plugins and frameworks such as WPBakery Page Builder and Yoast SEO. It integrates multiple third-party analytics and marketing tools including Google Analytics, Facebook Pixel, LinkedIn Insight Tag, and Twitter tracking. Hosting appears to be on a reputable managed WordPress platform, likely WP Engine, with Cloudflare DNS services. The site is mobile optimized and SEO friendly, though accessibility features are basic. From a security perspective, the site enforces HTTPS and uses domain locking status codes to protect domain integrity. However, DNSSEC is not enabled, and there is no visible advanced security policy or incident response information published. Privacy compliance is limited, with no explicit privacy or cookie policies or consent mechanisms detected, representing a compliance gap. No contact emails or phone numbers are publicly listed, only contact forms. Overall, the site is professional and trustworthy with a strong business credibility score but could improve privacy compliance and security transparency. Strategic recommendations include publishing comprehensive privacy and cookie policies, enabling DNSSEC, and adding security and incident response disclosures to enhance trust and compliance.

15
35
2
70
57
80
100
biosimilarshealthcareadvocacybiosimilarmedicinespolicy+3 more
WordPressWPBakery Page BuilderYoast SEOGoogle Custom Search+5

Partner Domains:

grxbiosims.org
partner
iqvia.com
partner

+1 more partners

2025-09-07T06:57:15.983Z
taro.ca favicon

Taro Pharmaceutical Industries Ltd.

taro.ca

53
HealthcareCanadalargeMEDIUM

Taro Pharmaceutical Industries Ltd. is a Canadian pharmaceutical company specializing in the development, manufacturing, and marketing of affordable prescription and over-the-counter medications. It operates as a subsidiary of Sun Pharma, a global healthcare company. The website serves healthcare professionals and consumers with product information, resources, and customer service. The company has a strong market position in the generic pharmaceutical sector in Canada, supported by its parent company’s global presence. Technically, the website is built on Drupal 7 with a technology stack including jQuery and Bootstrap. It is mobile optimized and provides a good user experience with clear navigation and professional design. Google Analytics and Google Tag Manager are used for analytics and tracking. However, some technical debt is evident, such as the use of an outdated jQuery version and lack of DNSSEC, which could pose security risks. From a security perspective, the site uses HTTPS and has domain transfer protections but lacks DNSSEC and explicit security headers. No incident response or security policies are publicly documented. Privacy compliance is basic, with a privacy policy and terms of use present but no cookie consent mechanism or GDPR compliance indicators. Contact information is limited to a contact form without direct emails or phone numbers visible. Overall, the website is legitimate, professional, and trustworthy but could improve its security posture and privacy compliance to better protect users and align with modern standards.

50
53
2
70
67
-
100
pharmaceuticalhealthcaregenericdrugscanadasunpharma+2 more
jQuery 1.10.2BootstrapDrupal 7Google Analytics

Partner Domains:

taro.com
subsidiary
sunpharma.com
parent

+1 more partners

2025-09-07T06:48:30.388Z
taro.com favicon

Taro Pharmaceutical Industries Ltd.

taro.com

66
HealthcareUnited StateslargeMEDIUM

Taro Pharmaceutical Industries Ltd. is a well-established pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. The company is now a wholly owned subsidiary of Sun Pharma, a global healthcare leader. The website reflects a corporate presence with sections dedicated to products, research, investor relations, and affiliated sites. The target audience includes healthcare professionals, investors, and consumers seeking pharmaceutical products. The business model focuses on pharmaceutical manufacturing, research, and distribution with a strong market position supported by its parent company Sun Pharma. Technically, the website is built on Drupal 7 with legacy jQuery libraries and uses several JavaScript plugins for UI components. The site is moderately optimized for mobile devices and has a good design and navigation structure. However, some technical debt is evident due to outdated libraries and lack of modern security headers. Hosting appears to be managed with AT&T DNS services, and no advanced analytics or tracking services were detected. From a security perspective, the site uses HTTPS (implied by the domain and typical corporate practice), but lacks DNSSEC and security headers. The WHOIS data shows a long-established domain with appropriate domain locks, indicating legitimacy. No explicit security or incident response policies are published, and no vulnerability disclosure or security.txt files were found. The site lacks a cookie consent mechanism, which may impact privacy compliance. Overall, the website is professional and trustworthy but could improve its security posture and privacy compliance. Strategic recommendations include upgrading outdated libraries, enabling DNSSEC, implementing security headers, and adding cookie consent mechanisms to enhance user trust and regulatory compliance.

60
53
2
87
67
85
100
pharmaceuticalhealthcarecorporateinvestor-relationsresearch
jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenu+2

Partner Domains:

sunpharma.com
parent
taro.ca
subsidiary

+3 more partners

2025-09-07T05:45:09.829Z
sandoz.ca favicon

Sandoz Canada

sandoz.ca

60
HealthcareCanadalargeMEDIUM

Sandoz Canada operates as a leading pharmaceutical company specializing in generic and biosimilar medicines, aiming to pioneer access to medicines for patients across Canada. The website targets patients, healthcare professionals, investors, media, and job seekers, providing comprehensive information about products, corporate responsibility, and career opportunities. The company positions itself as a leader in the Canadian generics and biosimilars market with a strong emphasis on quality and innovation. Technically, the website is built using modern web technologies including React with Next.js framework and Drupal CMS on the backend. It leverages Google Tag Manager for analytics and tracking, and is hosted on Amazee.io infrastructure. The site demonstrates good mobile optimization, clear navigation, and moderate performance, reflecting a mature digital presence. From a security perspective, the site enforces HTTPS with strong SSL configuration and includes some security headers, though explicit headers like X-Frame-Options and X-Content-Type-Options are not clearly visible. No vulnerabilities or exposed sensitive data were detected. However, the absence of visible privacy and cookie policies and lack of incident response or vulnerability disclosure information indicate areas for improvement in compliance and transparency. Overall, the website is professional, trustworthy, and safe for general audiences. The lack of public WHOIS data is typical for corporate domains using privacy protection and does not significantly detract from legitimacy. Strategic recommendations include enhancing privacy compliance, publishing security policies, and improving accessibility features to further strengthen trust and regulatory adherence.

55
35
2
40
95
75
100
healthcarepharmaceuticalsgenericsbiosimilarscanada
React (Next.js)Google Tag ManagerSlick Carousel
2025-09-07T05:44:59.810Z
natcopharma.ca favicon

Natco Pharma (Canada) Inc.

natcopharma.ca

50
HealthcareCanadamediumMEDIUM

Natco Pharma (Canada) Inc. is a Canadian subsidiary of Natco Pharma Limited, specializing in pharmaceutical manufacturing and supply. The company emphasizes vertical integration, controlling all stages from active pharmaceutical ingredients to finished dosage forms, ensuring quality and affordability. Established since 2006, Natco Pharma serves Canadian patients with a portfolio of globally approved medicines, positioning itself as a trusted pharmaceutical supplier in Canada. The website reflects a professional corporate presence with clear business information and regulatory trust indicators. Technically, the website is built on WordPress with WooCommerce and uses modern web technologies such as WPBakery Page Builder and Revolution Slider. The site is mobile optimized and includes SEO best practices, although some accessibility features are basic. Performance is moderate, with external dependencies on common CDNs and Google Analytics for tracking. From a security perspective, the site enforces HTTPS and uses secure plugins but lacks important security headers and a cookie consent mechanism, which impacts privacy compliance. No incident response or vulnerability disclosure information is provided, which could be improved to enhance trust. The absence of WHOIS data for the domain raises concerns about domain registration transparency, although the business legitimacy is supported by regulatory approvals and professional content. Overall, Natco Pharma (Canada) Inc. presents a credible pharmaceutical business with a solid digital presence but would benefit from enhanced security practices and privacy compliance measures to strengthen trust and regulatory adherence.

15
58
2
70
95
70
20
pharmaceuticalhealthcarecanadamedicinemanufacturing+2 more
WordPressWooCommerceWPBakery Page BuilderRevolution Slider+3

Partner Domains:

www.natcopharma.co.in
parent
2025-09-07T05:44:49.793Z